Nalaganje...
Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
Recent studies have suggested that liraglutide could have a potential function in improving non-alcoholic fatty liver disease (NAFLD); however, the underlying molecular mechanism remains unclear. The aim of the present study was to investigate the role of the AMP-activated protein kinase (AMPK)/ster...
Shranjeno v:
| izdano v: | Exp Ther Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665609/ https://ncbi.nlm.nih.gov/pubmed/26640549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2741 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|